End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.97 USD | +1.73% |
|
-0.80% | -2.25% |
Jun. 28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
Jun. 28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |